Malignant choroid melanoma
MONDO:0003878A uveal melanoma that arises from the choroid. It is the most common primary malignant intraocular tumor. It usually affects Caucasians of northern European descent. It usually remains asymptomatic for a long period. When signs and symptoms occur, they include blurred vision, visual field loss, floaters, and ocular pain. Tumor size is the most important factor that relates to prognosis.
Also known as: choroid malignant melanoma, choroid melanoma, choroidal melanoma, malignant melanoma of choroid, malignant melanoma of the choroid, melanoma (disease) of optic choroid, melanoma of choroid, melanoma of the choroid
2842 clinical trials for this condition and its sub-types, 10 tagged with Malignant choroid melanoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Malignant choroid melanoma
-
Choroid epithelioid cell melanoma 0 trials
-
Choroid mixed cell melanoma 0 trials
-
Choroid necrotic melanoma 0 trials
-
Choroid spindle cell melanoma 0 trials
-
New hope: eye injections may stop Radiation-Related blindness
Prevention Recruiting nowThis phase 3 trial tests whether two different eye treatments can prevent vision loss in people who have had radiation therapy for a type of eye cancer called uveal melanoma. The study will compare faricimab injections given every 3 months, a fluocinolone acetonide implant placed…
Phase 3 • Sponsor: Jaeb Center for Health Research • Aim: Prevention
Last updated Aug 22, 2026 00:00 UTC
-
How does eye cancer treatment affect daily life? new study aims to find out
Knowledge-focused Recruiting nowThis study tracks how choroidal melanoma and its treatment affect patients' quality of life. It involves 15 people already in a larger Phase 3 trial. Participants fill out questionnaires about their well-being over two years. No new drugs or procedures are tested here.
Sponsor: Aura Biosciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC